AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
SYMPTOMATIC EFFECTS OF METHOTREXATE, 5FLUOROURACIL AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER AFTER FAILURE OF 5FU CONTINUOUS-INFUSION
Authors: CASCINU S BATTELLI N SCARTOZZI M BALDELLI AM CELLERINO R
Citation: S. Cascinu et al., SYMPTOMATIC EFFECTS OF METHOTREXATE, 5FLUOROURACIL AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER AFTER FAILURE OF 5FU CONTINUOUS-INFUSION, GI cancer, 2(3), 1998, pp. 203-206
CISPLATIN, EPIRUBICIN AND CYCLOPHOSPHAMIDE (PEC) IN THE TREATMENT OF OVARIAN-CANCER - A REPORT ON A SERIES OF 116 PATIENTS
Authors: PIGA A MASSACESI C BASCIONI R ALESSANDRONI P CIAVATTINI A CELLERINO R
Citation: A. Piga et al., CISPLATIN, EPIRUBICIN AND CYCLOPHOSPHAMIDE (PEC) IN THE TREATMENT OF OVARIAN-CANCER - A REPORT ON A SERIES OF 116 PATIENTS, Annals of oncology, 9, 1998, pp. 342-342
CISPLATIN, DACARBAZINE, FOTEMUSTINE, AND INTERFERON-ALPHA-2B IN ADVANCED MELANOMA - A PHASE-II STUDY OF ITALIAN MELANOMA STUDY-GROUP (IMSG)
Authors: DAPONTE A COMELLA P CELLERINO R DELENA M BRANDI M MARINI G FAILLA G DEVITA F RIVELLINI F GRAVINA A MOZZILLO N CARACO C COMELLA G
Citation: A. Daponte et al., CISPLATIN, DACARBAZINE, FOTEMUSTINE, AND INTERFERON-ALPHA-2B IN ADVANCED MELANOMA - A PHASE-II STUDY OF ITALIAN MELANOMA STUDY-GROUP (IMSG), Annals of oncology, 9, 1998, pp. 560-560
ADVANCED NONSMALL CELL LUNG-CANCER (ANSCLC) IN THE ELDERLY - EFFECTIVE AND WELL TOLERATED WEEKLY GEMCITABINE (GEM) AND CISPLATIN (CDDP) REGIMEN
Authors: LIPPE P SILVA RR GIULIODORI L SANTO A CANCELLIERI MA MONTERUBBIANESI MC ROSSI D CELLERINO R
Citation: P. Lippe et al., ADVANCED NONSMALL CELL LUNG-CANCER (ANSCLC) IN THE ELDERLY - EFFECTIVE AND WELL TOLERATED WEEKLY GEMCITABINE (GEM) AND CISPLATIN (CDDP) REGIMEN, Annals of oncology, 9, 1998, pp. 69-69
A DOUBLE-BLIND RANDOMIZED STUDY OF ORAL CLODRONATE IN THE TREATMENT OF BONE METASTASES FROM TUMORS POORLY RESPONSIVE TO CHEMOTHERAPY
Authors: PIGA A BRACCI R FERRETTI B SANDRI P NORTILLI R ACITO L PANCOTTI A DIFURIA L CARLE F CELLERINO R
Citation: A. Piga et al., A DOUBLE-BLIND RANDOMIZED STUDY OF ORAL CLODRONATE IN THE TREATMENT OF BONE METASTASES FROM TUMORS POORLY RESPONSIVE TO CHEMOTHERAPY, Journal of experimental & clinical cancer research, 17(2), 1998, pp. 213-217
LOCOREGIONAL TREATMENTS OF UNRESECTABLE LIVER METASTASES FROM COLORECTAL-CANCER
Authors: CASCINU S CATALANO V BALDELLI AM SCARTOZZI M BATTELLI N GRAZIANO F CELLERINO R
Citation: S. Cascinu et al., LOCOREGIONAL TREATMENTS OF UNRESECTABLE LIVER METASTASES FROM COLORECTAL-CANCER, Cancer treatment reviews, 24(1), 1998, pp. 3-14
INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD)
Authors: CASCINU S LABIANCA R GRAZIANO F PANCERA G BARNI S FRONTINI L LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD), British Journal of Cancer, 78(3), 1998, pp. 390-393
GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY
Authors: CASCINU S FRONTINI L LABIANCA R SILVA R FERRETTI B BARNI S CATALANO G CELLERINO R
Citation: S. Cascinu et al., GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1268-1268
A PHASE-I STUDY OF PACLITAXEL AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER
Authors: CASCINU S FICARELLI R SAFI MAA GRAZIANO F CATALANO G CELLERINO R
Citation: S. Cascinu et al., A PHASE-I STUDY OF PACLITAXEL AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER, European journal of cancer, 33(10), 1997, pp. 1699-1702
LIVER METASTASES FROM COLORECTAL-CANCER
Authors: CASCINU S CATALANO V SCARTOZZI M BALDELLI AM CELLERINO R
Citation: S. Cascinu et al., LIVER METASTASES FROM COLORECTAL-CANCER, Annals of oncology, 8(4), 1997, pp. 393-399
INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER
Authors: CASCINU S LABIANCA R ALESSANDRONI P MARCELLINI M SILVA RR PANCERA G TESTA E MARTIGNONI G BARNI S FRONTINI L ZANIBONI A LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3313-3319
A PHASE-II STUDY OF INTERFERON-ALPHA AND LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
Authors: PIGA A GIORDANI P QUATTRONE A GIULIONI M DESIGNORIBUS G ANTOGNOLI S CELLERINO R
Citation: A. Piga et al., A PHASE-II STUDY OF INTERFERON-ALPHA AND LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Cancer immunology and immunotherapy, 44(6), 1997, pp. 348-351
A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES
Authors: TUMMARELLO D MARI D GRAZIANO F ISIDORI P CETTO G PASINI F SANTO A CELLERINO R
Citation: D. Tummarello et al., A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES, Cancer, 80(12), 1997, pp. 2222-2229
C-ERBB-2 AND COMMON PROGNOSTIC FACTORS IN BREAST-CANCER PATIENTS
Authors: CASCINU S BATTELLI N GRAZIANO F GHI MG SILVA RR NACCIARRITI D CELLERINO R
Citation: S. Cascinu et al., C-ERBB-2 AND COMMON PROGNOSTIC FACTORS IN BREAST-CANCER PATIENTS, Oncology Reports, 3(5), 1996, pp. 883-886
ATTITUDES OF NON-ONCOLOGY PHYSICIANS DEALING WITH CANCER-PATIENTS - ASURVEY BASED ON CLINICAL SCENARIOS IN ANCONA PROVINCE, CENTRAL ITALY
Authors: PIGA A GRAZIANO F ZAHRA G CELLERINO R
Citation: A. Piga et al., ATTITUDES OF NON-ONCOLOGY PHYSICIANS DEALING WITH CANCER-PATIENTS - ASURVEY BASED ON CLINICAL SCENARIOS IN ANCONA PROVINCE, CENTRAL ITALY, Tumori, 82(5), 1996, pp. 423-429
ASSESSING QUALITY-OF-LIFE IN PATIENTS WITH CANCER - A COMPARISON OF AVISUAL-ANALOG AND A CATEGORICAL MODEL
Authors: GIORGI F CELLERINO R GRAMAZIO A TUMMARELLO D MENICHETTI ET GIORDANI P ANTOGNOLI S CARLE F PIGA A
Citation: F. Giorgi et al., ASSESSING QUALITY-OF-LIFE IN PATIENTS WITH CANCER - A COMPARISON OF AVISUAL-ANALOG AND A CATEGORICAL MODEL, American journal of clinical oncology, 19(4), 1996, pp. 394-399
CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY
Authors: TUMMARELLO D GRAZIANO F ISIDORI P SANTO A CETTO G FEDELI A ROSSI G CELLERINO R
Citation: D. Tummarello et al., CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY, Cancer, 77(11), 1996, pp. 2251-2257
A PHASE-II RANDOMIZED TRIAL OF 5-FLUOROURACIL WITH OR WITHOUT INTERFERON ALPHA-2A IN ADVANCED COLORECTAL-CANCER
Authors: PIGA A CASCINU S LATINI L MARCELLINI M BAVOSI M ACITO L BASCIONI R GIUSTINI L FRANCINI G PANCOTTI A ROSSI G DELPAPA M CARLE F CELLERINO R
Citation: A. Piga et al., A PHASE-II RANDOMIZED TRIAL OF 5-FLUOROURACIL WITH OR WITHOUT INTERFERON ALPHA-2A IN ADVANCED COLORECTAL-CANCER, British Journal of Cancer, 74(6), 1996, pp. 971-974
QUANTITATIVE MR-IMAGING DATA IN THE EVALUATION OF HEPATIC METASTASES DURING SYSTEMIC CHEMOTHERAPY
Authors: GIOVAGNONI A PACI E TERILLI F CELLERINO R PIGA A
Citation: A. Giovagnoni et al., QUANTITATIVE MR-IMAGING DATA IN THE EVALUATION OF HEPATIC METASTASES DURING SYSTEMIC CHEMOTHERAPY, Journal of magnetic resonance imaging, 5(1), 1995, pp. 27-32
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
Authors: ALBERTI W ANDERSON G BARTOLUCCI A BELL D VILLALBA JB BRODIN O CARDIELLO C CARTEI F CARTEI G CELLERINO R CHASTANG C CORMIER Y COX JD CRINO L CROWLEY J DAUTZENBERG B DEPIERRE A DIETEMANN A DILLMAN RO DOI O FELD R FIGLIN R GANZ PA GREEN MR GREGOR A HELLE PA HERNDON JE HITOMI S HOST H IMAIZUMI M JETT JR JOHNSON D KAASA S KIMURA H KLASTERSKY J KONDO H KREISMAN H KRIS MG KUNISHIMA K KUWAHARA O LAD TE LAING AH MACBETH F MASAOKA A MATTSON K MINATEL E MIRA JG MORI T MOUNTAIN CF NIEDERLE N NIIRANEN A NOU E PAGE W PATER J PIANTADOSI S PISTERS KMW PYRHONEN S QUOIX E RAPP E ROWELL NP SAHMOUD T SAWAMURA K SCHALLIER DCC SCOTT C SIMPSON J STAGG M TERAMATSU T TROVO MG TSUCHIYA R TUMMARELLO D VANHOUTTE P VANZANDWIJK N VINCENT RG WADA H WHITE JE WILLIAMS CJ WOODS RL YAMAGUCHI Y ARRIAGADA R CARTMELLDAVIES J GIRLING DJ LECHEVALIER T MARSONI S PARMAR MKB PIGNON JP REKACEWICZ C SOUHAMI RL STEWART LA TARAYRE M TINAZZI A TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C
Authors: TUMMARELLO D GRAZIANO F ISIDORI P CELLERINO R
Citation: D. Tummarello et al., SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 249-253
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHEMOTHERAPY-ASSOCIATED ANEMIA
Authors: CASCINU S CATALANO G CELLERINO R
Citation: S. Cascinu et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHEMOTHERAPY-ASSOCIATED ANEMIA, Cancer treatment reviews, 21(6), 1995, pp. 553-564
SYNCHRONOUS PRIMARY HEPATIC LYMPHOMA AND EPIDERMOID LUNG-CARCINOMA TREATED WITH CHEMOTHERAPY AND SURGERY
Authors: GRAZIANO F CELLERINO R MENESTRINA F NICOLI N GRAMAZIO A LATINI L PIGA A
Citation: F. Graziano et al., SYNCHRONOUS PRIMARY HEPATIC LYMPHOMA AND EPIDERMOID LUNG-CARCINOMA TREATED WITH CHEMOTHERAPY AND SURGERY, American journal of clinical oncology, 18(3), 1995, pp. 194-198
THE CLINICAL IMPACT OF FEM REGIMEN (5-FLUOROURACIL, 4-EPIDOXORUBICIN AND MITOMYCIN-C) IN ADVANCED GASTRIC-CANCER PATIENTS
Authors: CASCINU S LATINI L FEDELI A GIORDANI P ANTOGNOLI S CATALANO G CELLERINO R
Citation: S. Cascinu et al., THE CLINICAL IMPACT OF FEM REGIMEN (5-FLUOROURACIL, 4-EPIDOXORUBICIN AND MITOMYCIN-C) IN ADVANCED GASTRIC-CANCER PATIENTS, Anticancer research, 15(6B), 1995, pp. 2781-2783
MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL
Authors: AMOROSO D BOCCARDO F BALESTRERO M MIGLIETTA L BREMA F CELLERINO R FARRIS A FOLCO U IACOBELLI S MESITI M
Citation: D. Amoroso et al., MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL, Breast cancer research and treatment, 33(3), 1995, pp. 265-268
Risultati: 1-25 | 26-34